AURORA CANNABIS INC (ACB) — SEC Filings

Latest SEC filings for AURORA CANNABIS INC (ACB), explained in plain English.

Sentiment Overview: 7 bullish, 41 neutral, 2 mixed

Recent Filings (50)

• Aurora Cannabis Files 6-K Report — 6-K · 2026-03-30T07:29:57-04:00 [neutral] Risk: low
  Aurora Cannabis Inc. filed a Form 6-K on March 30, 2026, reporting a news release dated the same day. The filing includes a news release as an exhibit, indicati
• 6-K Filing — 6-K · 2025-11-05T00:00:00.000Z [neutral]
• Aurora Cannabis Files 6-K for Q2 2025 — 6-K · 2025-11-05T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. filed a Form 6-K on November 5, 2025, for the period ending September 30, 2025. The company is incorporated in Alberta, Canada, and its pri
• Aurora Cannabis to Host Q2 2026 Investor Call — 6-K · 2025-10-23T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. announced on October 22, 2025, that it will host its second quarter 2026 investor conference call. The company, led by CEO Miguel Martin, i
• Aurora Cannabis Invests in German Facility — 6-K · 2025-09-18T00:00:00.000Z [neutral] Risk: medium
  Aurora Cannabis Inc. announced on September 18, 2025, a significant investment into its German manufacturing facility. This move is part of the company's strate
• Aurora Cannabis Holds 2025 Annual Meeting, Elects Directors — 6-K · 2025-08-11T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. announced the results of its 2025 Annual General and Special Meeting held on August 8, 2025. Key resolutions passed included the election o
• Aurora Cannabis Reports Q1 Fiscal 2026 Results — 6-K · 2025-08-06T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. announced its first quarter fiscal 2026 results on August 6, 2025. The company, led by CEO Miguel Martin, is listed on NASDAQ and TSX under
• Aurora Cannabis Files 6-K Report — 6-K · 2025-08-06T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. filed a Form 6-K on August 6, 2025, for the period ending June 30, 2025. The company is a foreign private issuer and is submitting its repo
• Aurora Cannabis Urges Shareholder Vote for 2025 AGM — 6-K · 2025-07-30T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. issued a Form 6-K on July 30, 2025, reminding shareholders to vote in advance of the proxy voting deadline for its 2025 Annual General Meet
• Aurora Cannabis Sets Q1 2026 Investor Call for Aug 8 — 6-K · 2025-07-24T00:00:00.000Z [neutral] Risk: medium
  Aurora Cannabis Inc. announced on July 23, 2025, that it will host its first quarter 2026 investor conference call on August 8, 2025. The call will discuss the
• Aurora Cannabis Secures EU-GMP Certification for Distribution Hub — 6-K · 2025-07-14T00:00:00.000Z [bullish] Risk: low
  Aurora Cannabis Inc. announced on July 14, 2025, that it has achieved EU-GMP certification for its dedicated distribution center. This certification is a signif
• Aurora Cannabis Files Management Circular — 6-K · 2025-07-09T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. announced on July 9, 2025, that it has filed and mailed its Management Information Circular for its upcoming annual general and special mee
• Aurora Cannabis Denounces Second False Investing.com Article — 6-K · 2025-06-20T00:00:00.000Z [neutral] Risk: medium
  Aurora Cannabis Inc. (ACB) issued a Form 6-K on June 20, 2025, to report a news release dated June 19, 2025. The news release addresses a second false article p
• Aurora Cannabis Files Full Year & Q4 Results — 6-K · 2025-06-18T00:00:00.000Z [neutral] Risk: medium
  Aurora Cannabis Inc. (NASDAQ: ACB) filed a Form 6-K on June 18, 2025, reporting its full-year results and announcing its fiscal 2025 fourth-quarter performance.
• Aurora Cannabis to Host Q4/FY25 Investor Call — 6-K · 2025-06-04T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. announced on June 3, 2025, that it will host an investor conference call to discuss its fourth quarter and fiscal year 2025 results. The co
• Aurora Cannabis Inc. Announces Shareholder Meeting Details — 6-K · 2025-05-27T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. filed a Form 6-K on May 27, 2025, to report a Notice of Meeting and Record Date. The filing indicates that the company is preparing for a s
• Aurora Cannabis Discovers Powdery Mildew Resistant Strains — 6-K · 2025-03-20T00:00:00.000Z [bullish] Risk: low
  Aurora Cannabis Inc. announced on March 20, 2025, a significant breakthrough with the discovery of new powdery mildew resistant cultivars. This discovery is exp
• Aurora Cannabis Eases Patient Access to Medical Cannabis — 6-K · 2025-02-18T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. announced on February 14, 2025, a news release detailing efforts to ease patient access to high-quality medical cannabis. The company, led
• Aurora Cannabis Strikes Supply Deal with SNDL — 6-K · 2025-02-07T00:00:00.000Z [neutral] Risk: medium
  Aurora Cannabis Inc. announced a supply agreement with SNDL Inc. on February 6, 2025. This agreement allows Aurora to supply dried cannabis flower to SNDL. Migu
• Aurora Cannabis Reports Q3 Fiscal 2025 Results — 6-K · 2025-02-05T00:00:00.000Z [neutral] Risk: medium
  Aurora Cannabis Inc. announced its fiscal 2025 third quarter results on February 5, 2025. The company filed a Form 6-K report with the SEC, which included a new
• Aurora Cannabis Files 6-K for Q3 2024 Period — 6-K · 2025-02-05T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. filed a Form 6-K on February 5, 2025, for the period ending December 31, 2024. The company is a foreign private issuer and is submitting it
• Aurora Cannabis to Host Q3 Fiscal 2025 Investor Call — 6-K · 2025-01-24T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. announced on January 22, 2025, that it will host its third quarter fiscal 2025 investor conference call. The call will discuss the company'
• Aurora Cannabis Reports Q2 Fiscal 2025 Results — 6-K · 2024-11-06T00:00:00.000Z [neutral] Risk: medium
  Aurora Cannabis Inc. announced its fiscal 2025 second quarter results on November 6, 2024. The company, led by CEO Miguel Martin, is incorporated in Alberta, Ca
• Aurora Cannabis Inc. Files 6-K with Financial Updates — 6-K · 2024-11-06T00:00:00.000Z [neutral] Risk: medium
  Aurora Cannabis Inc. filed a Form 6-K on November 6, 2024, for the period ending September 30, 2024. The filing includes condensed financial statements as Exhib
• Aurora Cannabis to Host Q2 2025 Investor Call Nov 14 — 6-K · 2024-10-25T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. announced on October 24, 2024, that it will host its second quarter fiscal year 2025 investor conference call on November 14, 2024. The cal
• Aurora Cannabis CEO Martin Adds Executive Chairman Role — 6-K · 2024-09-20T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. announced on September 20, 2024, that CEO Miguel Martin has assumed the additional role of Executive Chairman. This change follows the resi
• Aurora Cannabis Advances Auto-Flowering Research — 6-K · 2024-09-17T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. announced on September 17, 2024, that it has made significant advancements in its auto-flowering research, unveiling key insights into cann
• Aurora Cannabis Files Material Change Report — 6-K · 2024-08-26T00:00:00.000Z [neutral] Risk: medium
  Aurora Cannabis Inc. filed a Material Change Report on August 7, 2024, as part of its Form 6-K filing with the SEC. This report details significant events affec
• Aurora Cannabis Holds 2024 Annual Meeting, Elects Directors — 6-K · 2024-08-12T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. announced the results of its 2024 Annual General and Special Meeting held on August 12, 2024. Key resolutions passed included the election
• Aurora Cannabis Reports Positive Free Cash Flow for Q1 FY25 — 6-K · 2024-08-07T00:00:00.000Z [bullish] Risk: medium
  Aurora Cannabis Inc. announced its fiscal 2025 first quarter results on August 7, 2024, highlighting positive free cash flow. The company, led by CEO Miguel Mar
• Aurora Cannabis Files 6-K for Q1 2025 — 6-K · 2024-08-07T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. filed a Form 6-K on August 7, 2024, for the period ending June 30, 2024. This report is incorporated by reference into their F-10 registrat
• Aurora Cannabis Partners with Vectura Fertin Pharma — 6-K · 2024-08-06T00:00:00.000Z [neutral] Risk: medium
  Aurora Cannabis Inc. announced a commercial collaboration with Vectura Fertin Pharma, Inc. on August 1, 2024. This partnership aims to leverage Vectura Fertin P
• Aurora Cannabis Q1 2025 Investor Call Set for August 14 — 6-K · 2024-07-29T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. announced on July 29, 2024, that it will host its first quarter 2025 investor conference call on August 14, 2024. The call will discuss the
• Aurora Cannabis Inc. Files 6-K with Updated News Release — 6-K · 2024-07-26T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. filed an updated Form 6-K on July 26, 2024, to correct textual errors in its news release dated July 25, 2024. The filing is an amendment t
• Aurora Cannabis Expands German Operations with New Licenses — 6-K · 2024-07-25T00:00:00.000Z [bullish] Risk: medium
  Aurora Cannabis Inc. announced on July 25, 2024, that its German facility has received expanded cultivation and unique research licenses from the German Federal
• Aurora Cannabis Files Shareholder Meeting Circular — 6-K · 2024-07-11T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. announced on July 9, 2024, that it has filed and mailed its Management Information Circular for its upcoming annual general and special mee
• Aurora Cannabis Files AGM Documents — 6-K · 2024-07-09T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. filed a Form 6-K on July 9, 2024, to submit several documents related to its upcoming Annual General Meeting (AGM). These include the Manag
• Aurora Cannabis Changes Auditor to Ernst & Young LLP — 6-K · 2024-07-05T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. has filed a Form 6-K on July 5, 2024, to report a change in its auditor. The company has appointed Ernst & Young LLP as its new successor a
• Aurora Cannabis Files Full Year Results — 6-K · 2024-06-20T00:00:00.000Z [neutral] Risk: medium
  Aurora Cannabis Inc. filed its full-year results and announced its fiscal 2024 fourth-quarter performance on June 20, 2024. The company is reporting its results
• Aurora Cannabis to Host Q4 & FY24 Investor Call — 6-K · 2024-06-07T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. announced on June 7, 2024, that it will host an investor conference call to discuss its fourth quarter and fiscal year 2024 results. The co
• Aurora Cannabis Sets July 17th Shareholder Meeting — 6-K · 2024-05-28T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. filed a Form 6-K on May 28, 2024, announcing a virtual annual general meeting of shareholders to be held on July 17, 2024. The record date
• Aurora Cannabis Appoints New Director — 6-K · 2024-05-22T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. announced on May 15, 2024, the appointment of a new director to its board. This filing is a Form 6-K report for the month of May 2024, subm
• Aurora Cannabis Ships Medical Cannabis to New Zealand — 6-K · 2024-05-14T00:00:00.000Z [bullish] Risk: medium
  Aurora Cannabis Inc. announced on May 8, 2024, that it has made its first shipment of medical cannabis products to the New Zealand market. This marks a signific
• Aurora Cannabis Changes Auditor to PwC — 6-K · 2024-05-01T00:00:00.000Z [neutral] Risk: low
  Aurora Cannabis Inc. filed a Form 6-K on May 1, 2024, to report a change in its auditor. The company has appointed PricewaterhouseCoopers LLP as its new auditor
• Aurora Cannabis Repays $465M Convertible Notes — 6-K · 2024-03-01T00:00:00.000Z [bullish] Risk: low
  Aurora Cannabis Inc. announced on February 29, 2024, that it has completed the final repayment of its convertible senior notes, totaling approximately $465 mill
• Aurora Cannabis Announces CFO Transition, Completes Prior Transaction — 6-K · 2024-02-20T00:00:00.000Z [mixed] Risk: medium
  Aurora Cannabis Inc. announced a CFO transition on February 20, 2024, with Simona King stepping down as Chief Financial Officer. The company also confirmed the
• Aurora Cannabis Files 6-K, Incorporates Material Change Report — 6-K · 2024-02-16T00:00:00.000Z [neutral] Risk: medium
  Aurora Cannabis Inc. filed a 6-K report on February 16, 2024, for the month of February 2024, indicating it is a foreign private issuer. The filing incorporates
• Aurora Acquires MedReleaf Australia for AUD$50M, Boosts EBITDA — 6-K · 2024-02-08T00:00:00.000Z [bullish] Risk: low
  Aurora Cannabis Inc. (NASDAQ: ACB) announced on February 8, 2024, that it has acquired the remaining 90% equity interest in MedReleaf Australia for an enterpris
• Aurora Cannabis Files Q3 2024 Interim Financials for Dec 31, 2023 — 6-K · 2024-02-08T00:00:00.000Z [neutral] Risk: medium
  Aurora Cannabis Inc. filed a 6-K on February 8, 2024, for the period ending December 31, 2023, which includes their unaudited Condensed Consolidated Interim Fin
• Aurora Cannabis Reaffirms FY24 Positive EBITDA, Plans Share Consolidation — 6-K · 2024-01-31T00:00:00.000Z [mixed]
  Aurora Cannabis Inc. (NASDAQ: ACB) announced on January 31, 2024, that it expects to achieve positive annual Adjusted EBITDA for fiscal year 2024 and positive f